Medical Developments International Limited (ASX:MVP) has received a notice of change of interests of substantial holder from Regal Partners Funds Management Pty Limited and its associates, disclosing that their combined voting power in the company changed from 6.67% to 7.91%, representing a move from 7,516,972 votes to 8,906,690 votes, with the change occurring on 13 November 2026.
Key Points
- Regal Partners Funds Management Pty Limited and its associates filed a substantial holder change notice dated 17 November 2026 for Medical Developments International Limited (ASX:MVP).
- The substantial holder's voting power moved from 6.67% (7,516,972 votes) to 7.91% (8,906,690 votes), based on shares on issue of 112,658,324 as disclosed by the company on 29 September 2026.
- A series of sell transactions occurred between 14 August 2026 and 13 November 2026, affecting a total of 1,389,718 ordinary securities across eight separate transactions.
- The present relevant interest totals 7,516,972 ordinary shares held across five registered holders including UBS Nominees Pty Ltd, J.P. Morgan Nominees Australia Ltd, J.P. Morgan Prime Nominees Ltd, Merrill Lynch (Aus) Nominees Pty Ltd, and Palm Beach Nominees Pty Limited.
Substantial Holder Identity and Filing Date
The notice was lodged by Regal Partners Funds Management Pty Limited and its associates, which include Regal Partners Holdings Pty Limited and Regal Partners Limited (ACN 129 188 450). Regal Partners Funds Management Pty Limited holds ACN 107 576 821, while Regal Partners Holdings Pty Limited holds ACN 610 797 138. The filing was signed by Ilana Stringer in her capacity as Director of Regal Partners Funds Management Pty Limited. The previous notice to the company was given on 17 August 2026 and was dated 13 August 2026, with the change in interests recorded on 13 November 2026.
Details of Sell Transactions Between August and November 2026
According to the filing, Regal Partners Funds Management Pty Limited and its associates conducted eight sell transactions in ordinary securities of Medical Developments International between 14 August 2026 and 13 November 2026. These transactions involved 498,000 shares on 14 August, 115,218 on 17 August, 175,535 on 18 August, 75,892 on 20 August, 89,521 on 27 August, 61,813 on 31 August, 101,573 on 7 September, and 272,166 on 13 November 2026. The consideration disclosed for each transaction ranged from $28,081.65 to $224,647.80.
Present Relevant Interests Across Registered Holders
Following the changes, the filing discloses the present relevant interests held across five registered holders. UBS Nominees Pty Ltd holds 3,522,625 ordinary shares, with UBS AG, Australia Branch as the person entitled to be registered. J.P. Morgan Nominees Australia Ltd holds 1,234,206 ordinary shares on behalf of J.P. Morgan Securities PLC. J.P. Morgan Prime Nominees Ltd holds 2,121,259 ordinary shares. Merrill Lynch (Aus) Nominees Pty Ltd holds 269,640 ordinary shares on behalf of Merrill Lynch International Limited. Palm Beach Nominees Pty Limited holds 369,242 ordinary shares on behalf of Barrenjoey Markets Pty Limited.



Please wait processing your request...